MDxHealth Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions. MDxHealth 2020 Revenues Up 57 Percent Billable test volume for the company's ConfirmMDx and SelectMDx prostate cancer test fell year over year, but rose sequentially from the third quarter. Oppenheimer Initiates Coverage of MDxHealth at Outperform The investment bank cited its expectation for a positive coverage decision from Medicare for the company's SelectMDx prostate cancer test, among other reasons. MDxHealth Q3 2020 Revenues Drop 6 Percent For the three months ended Sept. 30, the Belgian molecular diagnostic firm's revenues fell to $4.5 million from $4.7 million in Q3 2019. MDxHealth H1 2020 Revenues Down 9 Percent on Declining Test Volumes The company said billable volume for its ConfirmMDx prostate cancer test fell 12 percent year over year, and volumes for its SelectMDx test fell 48 percent. Apr 27, 2020 MDxHealth Receives €12.7M Investment From MVM Partners Apr 9, 2020 MDxHealth Q1 Revenues Up 24 Percent; Company Suspends 2020 Guidance Feb 26, 2020 MDxHealth 2019 Revenues Fall 58 Percent Nov 11, 2019 MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period Oct 4, 2019 Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More Sep 26, 2019 MDxHealth Plans Private Placement, Signs $9.9M Loan Agreement Aug 29, 2019 MDxHealth H1 2019 Revenues Fall 37 Percent Aug 22, 2019 Local Coverage Determinations Roundup: MDxHealth, Myriad, AltheaDx, Natera, and More Apr 24, 2019 MDxHealth Q1 Revenues Drop 51 Percent Feb 28, 2019 MDxHealth Posts Flat Year-Over-Year Revenues for 2018 Feb 14, 2019 MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay Jan 14, 2019 MDxHealth Preliminary 2018 Revenues Drop Nearly 1 Percent Nov 26, 2018 MDxHealth Prostate Cancer Test Gains New York State Approval Oct 23, 2018 MDxHealth's Product Sales Jump but Lower Royalty Revenue Hits Top-Line Results Aug 30, 2018 MDxHealth H1 Revenues Fall 29 Percent Aug 15, 2018 MDxHealth Hopes to Build Lead in Prostate Risk Testing With Utility Evidence for SelectMDx Premium Jul 23, 2018 Palmetto Issues Positive Final LCD for MDxHealth Prostate Cancer Test Jun 6, 2018 MDxHealth Licenses Prognostic Prostate Cancer Biomarker From Philips Apr 24, 2018 MDxHealth Q1 Revenues Up 50 Percent Apr 20, 2018 In Brief This Week: SeraCare; Human Longevity; CareDx; Interpace Diagnostics; and More Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.